Buy & Sell STMicroelectronics NV (STM) – STMicroelectronics NV Price Today
Aura AI Summary
Key Stats
- $49.91BMarket Cap
- FinancialsSector
- -10.71%3M Drawdown
- $48.12BEnterprise Value
- 0.62%Dividend Yield
- 41% Buy | 59% SellTrading Activity
- 88 daysTypical Hold Time
STMicroelectronics NV (STM) is currently valued at a market capitalization of $49.91B, with an enterprise value of $48.12B. Over the past 52 weeks, STMicroelectronics NV has traded between a low of $21.2 and a high of $63.39, highlighting its annual price range. Over the past three months, STMicroelectronics NV has recorded a drawdown of -10.71%, reflecting recent price volatility. STMicroelectronics NV offers a dividend yield of 0.62%, with the most recent dividend of $0.09 paid on 24 Mar 26. On average, investors hold STMicroelectronics NV for approximately 88 days, indicating typical investor behavior on the platform.
About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Most Recent News
Pension officials criticize SpaceX's IPO structure as overly favorable to Elon Musk's control.
Top pension officials from New York and California have expressed concerns about SpaceX's upcoming IPO, criticizing its dual-class share structure that grants Elon Musk significant voting power and control. They warn that this 'most management-favora...
Ipsen presents corabotase, a novel neuro-inhibitor, showing promising phase II results for facial wrinkle treatment.
Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuro-inhibitors, at the SCALE symposium. Phase II trial data show corabotase's safety and efficacy in treating moderate to severe facial wrinkles, including glabellar ...
UK PM Starmer faces leadership challenge as rivals prepare bids, unsettling bond markets.
UK Prime Minister Keir Starmer is facing a potential leadership challenge as Health Secretary Wes Streeting may resign to launch a bid, while Angela Rayner and Andy Burnham are also possible contenders. This political uncertainty has unsettled UK bon...